Tag: stationary concentrator
Inogen makes play in stationary market
June 24, 2014HME News Staff
GOLETA, Calif. - Inogen has received clearance from the U.S. Food and Drug Administration (FDA) for a home oxygen concentrator called Inogen At Home. The company, better known for its portable oxygen concentrators (POCs), plans to start selling the devices later this year. “Inogen's release of the Inogen At Home, combined with its Inogen One family of products, positions the company with a complete product portfolio to be able to fulfill the clinical requirements of most oxygen therapy...
Food & Drug Administration (FDA), Inogen, stationary concentrator
Sponsored Stories
From Intake to Billing — SOS Handles It All for HME/DME Providers
By Strategic Office SupportHow Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office Support